Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis

Saved in:
Bibliographic Details
Published in:Discover Oncology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868938354969542656
collection WordPress RSS
FRELIP Feed Integration
container_title Discover Oncology
description
discipline_display Endocrinology
discipline_facet Endocrinology
format Online Article
RSS Article
genre Journal Article
id rss_article:95559
institution FRELIP
journal_source_facet Discover Oncology
last_indexed 2026-06-25T03:35:07.890Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
Endocrinology
General
Endocrinology
sub_discipline_display General
sub_discipline_facet General
subject_display Endocrinology
General
Endocrinology
subject_facet Endocrinology
General
Endocrinology
title Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
title_alt Niveles basales de vitamina D y supervivencia libre de progresión en pacientes con cáncer de mama metastásico HR+/HER2− tratadas con ribociclib: un análisis retrospectivo unicéntrico
Niveaux de base de vitamine D et survie sans progression chez les patientes atteintes d'un cancer du sein métastatique HR+/HER2− traitées par ribociclib : une analyse rétrospective monocentrique
Níveis basais de vitamina D e sobrevida livre de progressão em pacientes com câncer de mama metastático HR+/HER2− tratados com ribociclibe: uma análise retrospectiva de centro único
title_auth Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
title_es_txt Niveles basales de vitamina D y supervivencia libre de progresión en pacientes con cáncer de mama metastásico HR+/HER2− tratadas con ribociclib: un análisis retrospectivo unicéntrico
title_fr_txt Niveaux de base de vitamine D et survie sans progression chez les patientes atteintes d'un cancer du sein métastatique HR+/HER2− traitées par ribociclib : une analyse rétrospective monocentrique
title_full Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
title_fullStr Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
title_full_unstemmed Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
title_pt_txt Níveis basais de vitamina D e sobrevida livre de progressão em pacientes com câncer de mama metastático HR+/HER2− tratados com ribociclibe: uma análise retrospectiva de centro único
title_short Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
title_sort baseline vitamin d levels and progression-free survival in patients with hr+/her2−metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
topic Endocrinology
General
Endocrinology
url https://link.springer.com/article/10.1007/s12672-026-05502-2